Related references
Note: Only part of the references are listed.Hypertension and Neuroimaging Changes After Bevacizumab for Retinopathy of Prematurity
Grace Twitty et al.
PEDIATRICS (2020)
Impaired wound healing secondary to bevacizumab
Ji W. Ahn et al.
INTERNATIONAL WOUND JOURNAL (2019)
Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
Xuting Chen et al.
JOURNAL OF OPHTHALMOLOGY (2019)
Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
Yu-Shan Chang et al.
PLOS ONE (2019)
Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta
Johanna P. Laakkonen et al.
VASCULAR PHARMACOLOGY (2019)
Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity
Wei-Chi Wu et al.
JAMA OPHTHALMOLOGY (2015)
Bevacizumab and Wound-Healing Complications Mechanisms of Action, Clinical Evidence, and Management Recommendations for the Plastic Surgeon
Ketan Sharma et al.
ANNALS OF PLASTIC SURGERY (2013)
The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing
John B. Christoforidis et al.
CLINICAL OPHTHALMOLOGY (2013)
Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity
Tatsuhiko Sato et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model
John Christoforidis et al.
CLINICAL OPHTHALMOLOGY (2012)
Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?
M. Golshan et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Impact of bevacizumab chemotherapy on craniotomy wound healing Clinical article
Aaron J. Clark et al.
JOURNAL OF NEUROSURGERY (2011)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Review on Bevacizumab and Surgical Wound Healing An Important Warning to All Surgeons
Chad R. Cordon et al.
ANNALS OF PLASTIC SURGERY (2009)
Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma
Eric Jonasch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study
Mark Kozloff et al.
ONCOLOGIST (2009)
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab
FA Scappaticci et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Overview of bevacizumab: A new cancer therapeutic strategy targeting vascular endothelial growth factor
RJ Ignoffo
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2004)
Share Paper
